{"sourcedb":"DevicePMAs@therightstef","sourceid":"P930036_S001","text":"Approval to add the existing AFP assay performed on the ACS: 180 to a new generation of instrumentation, the Centaur and is indicated for the quantitative determination of alpha-fetoprotein (AFP) in the following: human serum and in amniotic fluid from specimens obtained at 15 to 20 weeks gestation, as an aid in detecting open neura tube defects (NTDs) when used in conjucntion with ultrasonography and amniography testing, using the Chiron Diagnostics ACS: Centaur(TM) Automated Chemiluminescence System.","project":"consensus_PMA_Age_Indications"}